申请人:ViroCura Therapeutics, Inc.
公开号:US20150133495A1
公开(公告)日:2015-05-14
Disclosed herein is a compound of Formula I
or a pharmaceutically acceptable salt thereof, in which A, G, R
1
and R
2
are as defined herein. The compounds and pharmaceutical compositions of the compounds are suitable for the treatment of HCV infection in mammals and are also useful to modulate or inhibit NS3/4 dimerization.
本文公开了一种I式化合物或其药学上可接受的盐,其中A、G、R1和R2的定义如本文所述。这些化合物及其制剂适用于哺乳动物HCV感染的治疗,并且也有用于调节或抑制NS3/4二聚体化的作用。